RecruitingNCT05776147

Radiotherapy With Extreme Hypofractionation in Patients With Breast Cancer in Brazil: a Retrospective Cohort Study

Sponsor

Latin American Cooperative Oncology Group

Enrollment

400 participants

Start Date

Nov 9, 2023

Study Type

OBSERVATIONAL

Conditions

Radiotherapy Side Effect

Summary

The radiotherapy scheme with extreme hypofractionation has gained space in clinical practice and, therefore, it is necessary to analyze the Brazilian national experience in selected patients with breast cancer, with the aim of evaluating the oncological outcomes and toxicities with the use of this treatment protocol.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a retrospective study (reviewing past medical records) looking at outcomes for women with breast cancer who received an ultra-short, 5-session radiation course (called extreme hypofractionation: 5 x 5.2 Gy) after surgery. The goal is to assess how safe and effective this shorter radiation schedule was in real-world clinical practice in Brazil. **You may be eligible if...** - You are a woman over 18 with a breast cancer diagnosis of any type - You were treated with extreme hypofractionated radiation (5 sessions of 5.2 Gy) after surgery - You were treated from December 2019 onward - Your clinical and treatment data are available in medical records **You may NOT be eligible if...** - There are no exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(11)

ICC - Instituto do Câncer do Ceará

Fortaleza, Ceará, Brazil

Hospital Sírio-Libanês DF

Brasília, Federal District, Brazil

Hospital Márcio Cunha da Fundação São Francisco Xavier (HMC-FSFX)

Ipatinga, Minas Gerais, Brazil

Oncominas - Clínica de Oncologia no Sul de Minas

Pouso Alegre, Minas Gerais, Brazil

Real Hospital Português de Beneficência em Pernambuco

Recife, Pernambuco, Brazil

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

Ribeirão Preto, São Paulo, Brazil

Instituto COI - Clínicas Oncológicas Integradas (Instituto Américas RJ)

Rio de Janeiro, Brazil

Hospital Sírio-Libanês SP

São Paulo, Brazil

HAOC - Hospital Alemão Oswaldo Cruz

São Paulo, Brazil

BP - A Beneficência Portuguesa de São Paulo

São Paulo, Brazil

A.C. Camargo Cancer Center

São Paulo, Brazil

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05776147

Related Trials

ALND vs ART in Positive Sentinel Node After Neoadjuvant Therapy in Breast Cancer

NCT0488992460 locations

Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First Years

NCT066187033 locations

Curatively Intended Thoracic Reirradiation

NCT069500731 location

Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

NCT0671944023 locations

RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3

NCT062979023 locations